Somatuline Depot ratings & reviews

Lanreotide
Company: Ipsen
Brand: Somatuline Depot
Drug class: Systemic Hormonal Agents (excluding Sex Hormones)
+3 more
Systemic Hormonal Agents (excluding Sex Hormones), Pituitary and Hypothalamic Hormones, Hypothalamic Hormones, Somatostatin and Analogs
Overall rating
3.7
full star full star full star half star empty star
Ranked #3
Physician ratings
  • Efficacy: effective for its intended use
  • Safety: safe to use in humans
  • Tolerability: low drug side effects
  • Accessibility: insurance/payer coverage, cost, affordability,formulary coverage, availability in your hospital or practice setting
  • Adherence: patient compliance with treatment
Efficacy
3.8/5
Safety
3.8/5
Tolerability
3.6/5
Accessibility
3.4/5
Adherence
3.7/5

Sermo AI Overview

  • Somatuline Depot is widely recognized for its strong efficacy in managing symptoms of carcinoid and is also highly regarded among physicians for treating low-grade malignant neuroendocrine tumors, with a focus on its safety and tolerability.
  • Despite its effectiveness, Somatuline Depot poses challenges related to high costs and varying accessibility, which can significantly impact patient choice and treatment adherence, particularly in cases of acromegaly.
  • Many specialists have noted that adherence to Somatuline Depot is generally manageable, especially for patients dealing with growth hormone excess, however, access limitations in certain regions may hinder treatment availability.
  • Was this summary helpful?
Based on insights from Sermo’s triple verified physicians

Description

Somatuline Depot contains lanreotide acetate, a synthetic analog of the hormone somatostatin. It is available as an injectable formulation in dosage strengths of 60 mg/0.2 mL, 90 mg/0.3 mL, and 120 mg/0.5 mL administered via deep subcutaneous injection. The formulation includes key inactive ingredients such as water for injection and acetic acid. Lanreotide acetate is a prolonged-release, sterile, ready-to-use preparation in single-dose prefilled syringes.

Source: This information is sourced from FDA and powered by AI

Dosage & Administration

How should I use this medication?

This medication is injected under the skin. It is given by your care team in a hospital or clinic setting.

Talk to your care team about the use of this medication in children. Special care may be needed.

Overdosage: If you think you have taken too much of this medicine contact a poison control center or emergency room at once.

NOTE: This medicine is only for you. Do not share this medicine with others.

What if I miss a dose?

Keep appointments for follow-up doses. It is important not to miss your dose. Call your care team if you are unable to keep an appointment.

Where should I keep my medication?

This medication is given in a hospital or clinic. It will not be stored at home.

NOTE: This sheet is a summary. It may not cover all possible information. If you have questions about this medicine, talk to your doctor, pharmacist, or health care provider.

Side Effects

What side effects may I notice from receiving this medication?

Side effects that you should report to your care team as soon as possible:

  • Allergic reactions—skin rash, itching, hives, swelling of the face, lips, tongue, or throat
  • Gallbladder problems—severe stomach pain, nausea, vomiting, fever
  • High blood sugar (hyperglycemia)—increased thirst or amount of urine, unusual weakness or fatigue, blurry vision
  • Increase in blood pressure
  • Low blood sugar (hypoglycemia)—pale, blue or purple skin or lips, sweating, fussiness, rapid heartbeat, poor feeding, low body temperature
  • Low thyroid levels (hypothyroidism)—unusual weakness or fatigue, increased sensitivity to cold, constipation, hair loss, dry skin, weight gain, feelings of depression
  • Oily or light-colored stools, diarrhea, bloating, weight loss
  • Slow heartbeat—dizziness, feeling faint or lightheaded, confusion, trouble breathing, unusual weakness or fatigue

Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):

  • Diarrhea
  • Dizziness
  • Headache
  • Muscle spasms
  • Nausea
  • Pain, redness, or irritation at injection site
  • Stomach pain

This list may not describe all possible side effects. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Warnings & Precautions

What should I tell my care team before I take this medication?

They need to know if you have any of these conditions:

  • Diabetes
  • Gallbladder disease
  • Heart disease
  • Kidney disease
  • Liver disease
  • Pancreatic disease
  • Thyroid disease
  • An unusual or allergic reaction to lanreotide, other medications, foods, dyes, or preservatives
  • Pregnant or trying to get pregnant
  • Breastfeeding

What may interact with this medication?

  • Bromocriptine
  • Cyclosporine
  • Certain medications for blood pressure, heart disease, irregular heartbeat
  • Certain medications for diabetes
  • Quinidine
  • Terfenadine

This list may not describe all possible interactions. Give your health care provider a list of all the medicines, herbs, non-prescription drugs, or dietary supplements you use. Also tell them if you smoke, drink alcohol, or use illegal drugs. Some items may interact with your medicine.

What should I watch for while using this medication?

Visit your care team for regular checks on your progress. Tell your care team if your symptoms do not start to get better or if they get worse.

Your condition will be monitored carefully while you are receiving this medication.

You may need blood work while you are taking this medication.

This medication may increase blood sugar. The risk may be higher in patients who already have diabetes. Ask your care team what you can do to lower your risk of diabetes while taking this medication.

Talk to your care team if you wish to become pregnant or think you may be pregnant. This medication can cause serious birth defects.

Do not breast-feed while taking this medication and for 6 months after stopping therapy.

This medication may cause infertility. Talk to your care team if you are concerned about your fertility.

Source: This information is sourced from Elsevier Inc.

Disclaimer

The reviews, ratings, comments, and opinions expressed on this platform are solely those of the individual medical professionals who posted them and do not reflect the views or positions of Sermo, Inc. Sermo does not endorse, verify, or validate the content of individual reviews. The information provided is user-generated and reflects personal clinical experiences, which may not be complete, accurate, or applicable to your specific health needs. It is not intended as medical advice.

Prescription medications affect individuals differently, and what works for one person may not work for another. Always consult your doctor, pharmacist, or other qualified healthcare provider to ensure the information displayed applies to your personal circumstances. Only a licensed healthcare provider can advise you on what is safe and effective for you.

Keep all medications out of the reach of children, never share your medicine with others, and use each medication only as prescribed. Your reliance on any information provided on this platform is at your own risk.

Terms of use

  1. Sermo Drug Ratings, and all information provided on this website, may not be used in combination with any artificial intelligence tool (including to train an algorithm, test, process, analyze, generate output and/or develop any form of artificial intelligence tool). 

  2. Visitors to the online patient-facing website at Sermo.com (“Sermo Drug Ratings”) are Authorized Users of the website, which contains data owned by a third-party provider, Elsevier, Inc.  Accordingly, by visiting Sermo Drug Ratings, Authorized User acknowledges that the website includes Elsevier owned data that Sermo licenses pursuant to a separate usage and Data agreement (the “Agreements”).  Authorized User further acknowledges that Sermo is a third-party beneficiary of the Agreements and Authorized User’s use of the website hereby binds them to the terms of the Agreements; provided, however, that Elsevier shall have no obligations or liability to an Authorized User whatsoever pursuant to the terms of the Agreements.

  3. Authorized User acknowledges and agrees that the Elsevier Products are designed for and are intended to be used by those residing in the United States, and that the information contained in the Elsevier Products does not comply with any laws or practices outside of the United States. You assume all responsibilities, duties, and obligations for any treatment, decision, or advice made or given to third parties as a result of the use or application of the Elsevier Products outside of the United States, and Sermo, Elsevier and its affiliates, subsidiaries, agents and suppliers will incur no liability for any use or application of the Products by Authorized Users outside of the United States.

Welcome to Sermo's Drug Ratings

Previously only for members, Sermo Drug Ratings are now openly available to all healthcare providers, patients, and industry professionals to support better healthcare decisions.

Clinical expertise
Insights based on real prescribing experience from triple-verified practicing physicians only
Detailed insights
Ratings on key attributes including efficacy, safety, tolerability, accessibility, and adherence
Unbiased reviews
Independent, physician-only reviews, free from pharmaceutical industry influence